Pasar al contenido principal

SISTEMAS DE REGULACION GENOMICA: ENSEÑANZAS DEL DESARROLLO DE RATON Y NUEVOS ABORDAJES PARA EL ESTUDIO DE LAS ENFERMEDADES HUMANAS

BFU2017-84914-P

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Essential roles of cohesin STAG2 in mouse embryonic development and adult tissue homeostasis

  • De Koninck, Magali
  • Lapi, Eleonora
  • Badía Careaga, Claudio
  • Cossío, Itziar
  • Giménez-Llorente, Daniel
  • Rodríguez-Corsino, Miriam
  • Andrada, Elena
  • Hidalgo, Andrés
  • Manzanares, Miguel
  • Real, Francisco X.
  • Losada, Ana
Cohesin mediates sister chromatid cohesion and 3D genome folding. Two versions of the complex carrying STAG1 or STAG2 coexist in somatic vertebrate cells. STAG2 is commonly mutated in cancer, and germline mutations have been identified in cohesinopathy patients. To better understand the underlying pathogenic mechanisms, we report the consequences of Stag2 ablation in mice. STAG2 is largely dispensable in adults, and its tissue-wide inactivation does not lead to tumors but reduces fitness and affects both hematopoiesis and intestinal homeostasis. STAG2 is also dispensable for murine embryonic fibroblasts in vitro. In contrast, Stag2-null embryos die by mid-gestation and show global developmental delay and defective heart morphogenesis, most prominently in structures derived from secondary heart field progenitors. Both decreased proliferation and altered transcription of tissue-specific genes contribute to these defects. Our results provide compelling evidence on cell- and tissue-specific roles of different cohesin complexes and how their dysfunction contributes to disease., This work has been supported by the State Research Agency (AEI), Spanish Ministry of Science and Innovation, with cofunding of the European Regional Development Funds (grants BFU2013-48481-R and BFU2016-79841-R to A.L., SAF2015-70553-R to F.X.R., BFU2017-84914-P and BFU2015-72319-EXP to M.M., and BES-2014-069166 fellowship to M.D.K.), and a grant to F.X.R. and a Postdoctoral Contract to E.L. from the Fundación Científica de la Asociación Española Contra el Cáncer. Both CNIO and CNIC are supported by Instituto de Salud Carlos III (ISCIII) and Severo Ochoa Centers of Excellence (SEV-2015-0510 and SEV-2015-0505). The CNIC is also supported by the Pro CNIC Foundation.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1

  • Sainz de Aja, Julio
  • Menchero, Sergio
  • Rollan, Isabel
  • Barral, Antonio
  • Tiana, Maria
  • Jawaid, Wajid
  • Cossio, Itziar
  • Alvarez, Alba
  • Carreño-Tarragona, Gonzalo
  • Badia-Careaga, Claudio
  • Nichols, Jennifer
  • Göttgens, Berthold
  • Isern, Joan
  • Manzanares, Miguel
Includes supplementary materials: online appendix; replication data, Progenitors of the first hematopoietic cells in the mouse arise in the early embryo from Brachyury-positive multipotent cells in the posterior-proximal region of the epiblast, but the mechanisms that specify primitive blood cells are still largely unknown. Pluripotency factors maintain uncommitted cells of the blastocyst and embryonic stem cells in the pluripotent state. However, little is known about the role played by these factors during later development, despite being expressed in the postimplantation epiblast. Using a dual transgene system for controlled expression at postimplantation stages, we found that Nanog blocks primitive hematopoiesis in the gastrulating embryo, resulting in a loss of red blood cells and downregulation of erythropoietic genes. Accordingly, Nanog-deficient embryonic stem cells are prone to erythropoietic differentiation. Moreover, Nanog expression in adults prevents the maturation of erythroid cells. By analysis of previous data for NANOG binding during stem cell differentiation and CRISPR/Cas9 genome editing, we found that Tal1 is a direct NANOG target. Our results show that Nanog regulates primitive hematopoiesis by directly repressing critical erythroid lineage specifiers., This work was supported by the Spanish government (grant BFU2014-54608-P and BFU2017-84914-P to MM; grants RYC-2011-09209 and BFU-2012-35892 to JI). The Gottgens and Nichols laboratories are supported by core funding from the Wellcome Trust and MRC to the Wellcome and MRC Cambridge Stem Cell Institute. The CNIC is supported by the Spanish Ministry of Science, Innovation and Universities (MINECO) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhancer-associated H3K4 methylation safeguards in vitro germline competence

  • Bleckwehl, Tore
  • Crispatzu, Giuliano
  • Schaaf, Kaitlin
  • Respuela, Patricia
  • Bartusel, Michaela
  • Benson, Laura
  • Clark, Stephen J.
  • Dorighi, Kristel M.
  • Barral, Antonio
  • Laugsch, Magdalena
  • Ijcken, Wilfred F. J.van
  • Manzanares, Miguel
  • Wysocka, Joanna
  • Reik, Wolf
  • Rada-Iglesias, Álvaro
© The Author(s) 2021., Germline specification in mammals occurs through an inductive process whereby competent cells in the post-implantation epiblast differentiate into primordial germ cells (PGC). The intrinsic factors that endow epiblast cells with the competence to respond to germline inductive signals remain unknown. Single-cell RNA sequencing across multiple stages of an in vitro PGC-like cells (PGCLC) differentiation system shows that PGCLC genes initially expressed in the naïve pluripotent stage become homogeneously dismantled in germline competent epiblast like-cells (EpiLC). In contrast, the decommissioning of enhancers associated with these germline genes is incomplete. Namely, a subset of these enhancers partly retain H3K4me1, accumulate less heterochromatic marks and remain accessible and responsive to transcriptional activators. Subsequently, as in vitro germline competence is lost, these enhancers get further decommissioned and lose their responsiveness to transcriptional activators. Importantly, using H3K4me1-deficient cells, we show that the loss of this histone modification reduces the germline competence of EpiLC and decreases PGCLC differentiation efficiency. Our work suggests that, although H3K4me1 might not be essential for enhancer function, it can facilitate the (re)activation of enhancers and the establishment of gene expression programs during specific developmental transitions., Tore Bleckwehl was supported by a doctoral fellowship from the Studienstiftung des deutschen Volkes (Germany). Giuliano Crispatzu is supported by funding within the CRU329 (DFG 386793560). Kaitlin Schaaf was supported by a Research Internships in Science and Engineering (RISE) Scholarship of the Deutscher Akademischer Austauschdienst (DAAD). Work in the Rada-Iglesias laboratory was supported by CMMC intramural funding (Germany), the German Research Foundation (DFG) (Research Grant RA 2547/2-1), “Programa STAR-Santander Universidades, Campus Cantabria Internacional de la convocatoria CEI 2015 de Campus de Excelencia Internacional” (Spain), the Spanish Ministry of Science, Innovation, and Universities (Research Grant PGC2018-095301-B-I00) and the European Research Council (ERC CoG “PoisedLogic”; 862022). AB and MM were supported by the Spanish Ministry of Science, Innovation, and Universities (BFU2017-84914-P), and the CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Spanish Ministry of Science, Innovation, and Universities, and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Open Access funding enabled and organized by Projekt DEAL.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pluripotency factors regulate the onset of Hox cluster activation in the early embryo

  • Tiana, María
  • López-Jiménez, Elena
  • Sainz de Aja, Julio
  • Barral, Antonio
  • Victorino, Jesús
  • Badía-Careaga, Claudio
  • Rollán, Isabel
  • Rouco, Raquel
  • Santos, Elisa
  • Sánchez-Iranzo, Héctor
  • Acemel, Rafael D.
  • Torroja, Carlos
  • Adán, Javier
  • Andrés-León, Eduardo
  • Gómez-Skarmeta, José Luis
  • Giovinazzo, Giovanna
  • Sánchez-Cabo, Fátima
  • Manzanares, Miguel
Pluripotent cells are a transient population of the mammalian embryo dependent on transcription factors, such as OCT4 and NANOG, which maintain pluripotency while suppressing lineage specification. However, these factors are also expressed during early phases of differentiation, and their role in the transition from pluripotency to lineage specification is largely unknown. We found that pluripotency factors play a dual role in regulating key lineage specifiers, initially repressing their expression and later being required for their proper activation. We show that Oct4 is necessary for activation of HoxB genes during differentiation of embryonic stem cells and in the embryo. In addition, we show that the HoxB cluster is coordinately regulated by OCT4 binding sites located at the 3′ end of the cluster. Our results show that core pluripotency factors are not limited to maintaining the precommitted epiblast but are also necessary for the proper deployment of subsequent developmental programs., This work was funded by the Spanish government (grants BFU2017-84914-P and PID2020-115755GB-I00 to M.M.; BFU2016-74961-P and BFU2016-81887-REDT to J.L.G.-S.), the Andalusian government (grant BIO-396 to J.L.G.-S.), and the European Research Council (ERC; grant agreement 740041 to J.L.G.-S.). M.T. held Juan de la Cierva fellowships from the Spanish government (FJCI-2017-31791 and IJC2019-038897-I), R.R. and R.D.A. held FPU fellowships from the government, and J.V. was the recipient of a “La Caixa” fellowship. Work in the laboratory of J.L.G.-S. was supported by a María de Maetzu Unit of Excellence Grant (MDM-2016-0687) to the Department of Gene Regulation and Morphogenesis of the CABD. The CBMSO is supported by an institutional grant from the Fundación Ramon Areces, and the CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). : With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020-001041-S).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A protocol to study three-dimensional genome structure in individual mutant preimplantation mouse embryos

  • Giménez-Llorente, Daniel
  • Portela, Marta
  • Losada, Ana
  • Manzanares, Miguel
  • Andreu, María José
Hi-C studies the three-dimensional structure of the genome by detecting genome-wide chromatin regions that are in spatial proximity within the nucleus. We developed single-blastocyst Hi-C in mutant mouse embryos to genotype them on sequence. We describe steps for embryo fixation and nuclei permeabilization, after which chromatin is digested and re-ligated having incorporated a biotin-labeled nucleotide at the ligation junction. After cross-link reversal, we then detail purification of immobilized chimeric DNA ligations, library generation, sequencing, and genome-wide analysis of interactions. For complete details on the use and execution of this protocol, please refer to Andreu et al. (2022)., This work was supported by grants PID2020-115755GB-I00, BFU2017-84914-P, and BFU2015-72319-EXP to M.M.; PID2019-106499RB-I00 to A.L.; FJCI-2014-19847 to M.J.A.; and PRE2018-083477 to M.P., funded by MCIN/AEI/10.13039/501100011033. The CBMSO is supported by an institutional grant from the Fundación Ramón Areces and is a Severo Ochoa Center of Excellence (grant CEX2021-001154-S funded by MICIN/AEI/10.13039/501100011033). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). The CNIO is a Severo Ochoa Center of Excellence (grant CEX2019-000891-S funded by MICIN/AEI/10.13039/501100011033).Graphical abstract was created with BioRender.com
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Chromatin dynamics through mouse preimplantation development revealed by single molecule localisation microscopy

  • Portela, Marta
  • Jimenez-Carretero, Daniel
  • Labrador, Veronica
  • Andreu, Maria Jose
  • Arza, Elvira
  • Caiolfa, Valeria R.
  • Manzanares, Miguel
Most studies addressing chromatin behaviour during preimplantation development are based on biochemical assays that lack spatial and cell-specific information, crucial during early development. Here, we describe the changes in chromatin taking place at the transition from totipotency to lineage specification, by using direct stochastical optical reconstruction microscopy (dSTORM) in whole-mount embryos during the first stages of mouse development. Through the study of two post-translational modifications of Histone 3 related to active and repressed chromatin, H3K4me3 and H3K9me3 respectively, we obtained a time-course of chromatin states, showing spatial differences between cell types, related to their differentiation state. This analysis adds a new layer of information to previous biochemical studies and provides novel insight to current models of chromatin organisation during the first stages of development., This work was supported by grants BFU2017-84914-P and PID2020-115755GB-I00 from the Spanish State Research Agency (AEI). M.P. was supported by fellowships from the Comunidad de Madrid (PEJD-2018-PRE/BMD-9079) and the Ministerio de Ciencia e Innovación (PRE2018-083477). The CBMSO is supported by an Institutional grant from the Fundación Ramon Areces, and the the CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence grant (CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033). Deposited in PMC for immediate release.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Establishment of 3D chromatin structure after fertilization and the metabolic switch at the morula-to-blastocyst transition require CTCF

  • Andreu, Maria Jose
  • Alvarez-Franco, Alba
  • Portela, Marta
  • Gimenez-Llorente, Daniel
  • Cuadrado, Ana
  • Badía-Careaga, Claudio
  • Tiana, María
  • Losada, Ana
  • Manzanares, Miguel
The eukaryotic genome is organized in 3D at different scales. This structure is driven and maintained by different chromatin states and by architectural factors, such as the zinc finger protein CTCF. Zygotic genome structure is established de novo after fertilization, but its impact during the first stages of mammalian development is unclear. We show that deletion of Ctcf in mouse embryos impairs the establishment of chromatin structure, but the first cell fate decision is unperturbed and embryos are viable until the late blastocyst. Furthermore, maternal CTCF is not necessary for development. Gene expression changes in metabolic and protein homeostasis programs that occur during the morula-to-blastocyst transition depend on CTCF. However, these changes do not correlate with disruption of chromatin but with binding of CTCF to the promoter of downregulated genes. Our results show that CTCF regulates both 3D genome organization and transcription during mouse preimplantation development, but as independent processes., We thank Sneha Gopalan and Tom Fazzio for advice and support; Diana Guallar, Miguel Fidalgo, and Marı´a Gomez for advice; Niels Galjart for the Ctcf mutant mice; Sergio Menchero for drawings of embryos; Antonio Barral and present and past members of the Manzanares lab for support, discussion and ideas. This work was supported by grants PID2020-115755GB-I00, BFU2017-84914-P, and BFU2015-72319-EXP to M.M.; PID2019-106499RBI00 to A.L.; PRE2018-083477 to M.P.; and IJC2019-038897-I to M.T., funded by MCIN/AEI/10.13039/501100011033. The CBMSO is supported by an institutional grant from the Fundacio´ n Ramo´ n Areces, and the CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/ 501100011033).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Essential roles of cohesin STAG2 in mouse embryonic development and adult tissue homeostasis

  • De Koninck, Magali
  • Lapi, Eleonora
  • Badía Careaga, Claudio
  • Cossío, Itziar
  • Giménez-Llorente, Daniel
  • Rodríguez-Corsino, Miriam
  • Andrada, Elena
  • Hidalgo, Andrés
  • Manzanares, Miguel
  • Real, Francisco X.
  • Losada, Ana
Cohesin mediates sister chromatid cohesion and 3D genome folding. Two versions of the complex carrying STAG1 or STAG2 coexist in somatic vertebrate cells. STAG2 is commonly mutated in cancer, and germline mutations have been identified in cohesinopathy patients. To better understand the underlying pathogenic mechanisms, we report the consequences of Stag2 ablation in mice. STAG2 is largely dispensable in adults, and its tissue-wide inactivation does not lead to tumors but reduces fitness and affects both hematopoiesis and intestinal homeostasis. STAG2 is also dispensable for murine embryonic fibroblasts in vitro. In contrast, Stag2-null embryos die by mid-gestation and show global developmental delay and defective heart morphogenesis, most prominently in structures derived from secondary heart field progenitors. Both decreased proliferation and altered transcription of tissue-specific genes contribute to these defects. Our results provide compelling evidence on cell- and tissue-specific roles of different cohesin complexes and how their dysfunction contributes to disease., This work has been supported by the State Research Agency (AEI), Spanish Ministry of Science and Innovation, with cofunding of the European Regional Development Funds (grants BFU2013-48481-R and BFU2016-79841-R to A.L., SAF2015-70553-R to F.X.R., BFU2017-84914-P and BFU2015-72319-EXP to M.M., and BES-2014-069166 fellowship to M.D.K.), and a grant to F.X.R. and a Postdoctoral Contract to E.L. from the Fundación Científica de la Asociación Española Contra el Cáncer. Both CNIO and CNIC are supported by Instituto de Salud Carlos III (ISCIII) and Severo Ochoa Centers of Excellence (SEV-2015-0510 and SEV-2015-0505). The CNIC is also supported by the Pro CNIC Foundation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1

  • Sainz de Aja, Julio
  • Menchero, Sergio
  • Rollan, Isabel
  • Barral, Antonio
  • Tiana, Maria
  • Jawaid, Wajid
  • Cossio, Itziar
  • Alvarez, Alba
  • Carreño-Tarragona, Gonzalo
  • Badia-Careaga, Claudio
  • Nichols, Jennifer
  • Göttgens, Berthold
  • Isern, Joan
  • Manzanares, Miguel
Includes supplementary materials: online appendix; replication data, Progenitors of the first hematopoietic cells in the mouse arise in the early embryo from Brachyury-positive multipotent cells in the posterior-proximal region of the epiblast, but the mechanisms that specify primitive blood cells are still largely unknown. Pluripotency factors maintain uncommitted cells of the blastocyst and embryonic stem cells in the pluripotent state. However, little is known about the role played by these factors during later development, despite being expressed in the postimplantation epiblast. Using a dual transgene system for controlled expression at postimplantation stages, we found that Nanog blocks primitive hematopoiesis in the gastrulating embryo, resulting in a loss of red blood cells and downregulation of erythropoietic genes. Accordingly, Nanog-deficient embryonic stem cells are prone to erythropoietic differentiation. Moreover, Nanog expression in adults prevents the maturation of erythroid cells. By analysis of previous data for NANOG binding during stem cell differentiation and CRISPR/Cas9 genome editing, we found that Tal1 is a direct NANOG target. Our results show that Nanog regulates primitive hematopoiesis by directly repressing critical erythroid lineage specifiers., This work was supported by the Spanish government (grant BFU2014-54608-P and BFU2017-84914-P to MM; grants RYC-2011-09209 and BFU-2012-35892 to JI). The Gottgens and Nichols laboratories are supported by core funding from the Wellcome Trust and MRC to the Wellcome and MRC Cambridge Stem Cell Institute. The CNIC is supported by the Spanish Ministry of Science, Innovation and Universities (MINECO) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).